Related Experiment Video

Updated: Jul 31, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Yeh Chin1, Khanisyah E Gumilar1,2, Xing-Guo Li1,3

  • 1Graduate Institute of Biomedical Sciences and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan, R.O.C.

Theranostics
|May 8, 2023
PubMed

Insights

Heat Shock Factor 1 (HSF1) regulates cellular stress responses and is crucial in cancer development. Research highlights new HSF1 functions and inhibitors for innovative cancer therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Stress Response

Background:

  • Heat Shock Factor 1 (HSF1) is a key regulator of cellular heat shock signaling.
  • Emerging evidence implicates HSF1 in non-heat shock stress responses, including metabolic, chemical, and genetic stress.
  • HSF1's role in cellular transformation and cancer development is a significant area of recent research.

Purpose of the Study:

  • To review the essential roles and mechanisms of HSF1 in cancer cells.
  • To focus on recently discovered HSF1 functions and their underlying mechanisms.
  • To highlight advances in HSF1 inhibitors for cancer drug development.

Main Methods:

  • Literature review of recent studies on HSF1 in cancer.
  • Analysis of molecular mechanisms underlying HSF1 functions.
  • Examination of current developments in HSF1-targeted cancer therapeutics.

Main Results:

  • HSF1 plays critical roles in cellular stress response and cancer development.
  • New functions and molecular mechanisms of HSF1 are continuously being discovered.
  • These discoveries offer potential new targets for cancer treatment strategies.

Conclusions:

  • HSF1 is a vital factor in cancer biology, involved in various stress responses.
  • Understanding HSF1's diverse roles provides insights into cancer progression.
  • Advances in HSF1 inhibitors show promise for future cancer drug development.
Keywords:
HSF1Heat shock responsecancercellular stress

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K